| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbe1d40faa1ed62003e4b49d8b278688 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-232
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-231
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2004-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9309e98457555b5b25576c6e5fb8aa49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c2216d20d638790ba450a4715a3993a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec31cf89dc43682da28beed2fcadd67d |
| publicationDate |
2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2311450-A1 |
| titleOfInvention |
Use of Triglyceride Oils Containing Gamma-Linolenic Acid Residues and Linoleic Acid Residues for the Treatment of a Neurodegenerative Disease |
| abstract |
A triglyceride oil is provided containing both γ-linolenic acid and linoleic acid residues as triglyceride ester for the treatment of neurodegenerative disease wherein the oil is administered at a dose sufficient to elevate or maintain TGF-β1 levels in the patient to or at a therapeutic level such as to produce a TGF-β1/TNF-α ratio of at least 0.5 in blood of a patient, after 18 months of daily dosing characterised in that the oil is obtained from a fungus of Mucor species; the ratio of γ-linolenic acid to linoleic acid residues at the sn-2 position of the triglyceride is at least 0.8; the amount of γ-linolenic acid residues at the sn-2 position is at least 18%, the dose is sufficient to administer at least 1 gram of γ-linolenic acid residues, as residues in the sn-2 position, excluding other γ-linolenic acid content of the oil. |
| priorityDate |
2003-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |